MolNFT v1 · #109390 · protein
Ytterbium-bound human serum transferrin
4X1D · Serotransferrin: “Ytterbium-bound human serum transferrin”. X-ray diffraction, 1 ligand (YB), 12 pockets (best druggability 0.77). MolNFT v1 #109390 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4X1D
- Type
- protein
- Length
- 1,316 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Serotransferrin
- UniProt
- P02787
- Ligands
- YB
- Pockets
- 12 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Serotransferrin | protein | 658 | 36% helix, 19% strand | P02787 |
Ligands and binding sites
- YB · Ytterbium (III) ion · metal · 2 copies · chains A, B
- MLI · Malonate ion · additive · 2 copies · chains A, B
- GOL · Glycerol · additive · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 854 | 0.77 | 0.81 | 78 | MLI |
| 2 | 858 | 0.77 | 0.80 | 84 | MLI |
| 3 | 1147 | 0.76 | 0.79 | 97 | GOL |
| 4 | 686 | 0.76 | 0.82 | 64 | GOL |
| 5 | 84 | 0.48 | 0.82 | 17 | empty |
Interfaces
1 interface between chains.
- A–B · 651 Ų buried · 18 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 34 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P02787
- Elsewhere: RCSB PDB 4X1D · PDBe 4X1D · UniProt P02787
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.